JPMorgan Chase & Co

JPMorgan Chase & Co Portfolio holdings

AUM $1.45T
1-Year Return 22.34%
 

JPMorgan Chase & Co., formed by the 2000 merger of J.P. Morgan & Co. and Chase Manhattan Bank, is a global financial services giant headquartered in New York City, tracing its roots back to 1799 through its predecessor firms. As one of the largest banks in the world, it operates across investment banking, commercial banking, asset management, and consumer banking, managing trillions in assets and serving millions of customers, corporations, and governments. Led by CEO Jamie Dimon since 2005, the firm is renowned for its role in high-profile deals, robust trading operations, and its Chase retail banking network, which includes extensive credit card and mortgage services. Combining a legacy of financial innovation with a dominant market presence, JPMorgan Chase remains a cornerstone of the global economy.

This Quarter Return
+13.64%
1 Year Return
+22.34%
3 Year Return
+87.94%
5 Year Return
+157.74%
10 Year Return
+357.7%
AUM
$1.45T
AUM Growth
+$141B
Cap. Flow
+$5.68B
Cap. Flow %
0.39%
Top 10 Hldgs %
26.46%
Holding
6,883
New
436
Increased
2,262
Reduced
2,874
Closed
680

Sector Composition

1 Technology 25.87%
2 Financials 10.43%
3 Consumer Discretionary 10.13%
4 Communication Services 7.61%
5 Healthcare 7.59%
Name Market Value Portfolio Weight Shares or Principal Shares
Change %
Capital Flow
WHWK
5526
Whitehawk Therapeutics, Inc. Common Stock
WHWK
$94.7M
$787 ﹤0.01%
421
-1,341
-76% -$2.51K
TMC icon
5527
TMC The Metals Company
TMC
$2.1B
$785 ﹤0.01%
+119
New +$785
SST icon
5528
System1
SST
$70.4M
$779 ﹤0.01%
141
-3,703
-96% -$20.5K
QNCX icon
5529
Quince Therapeutics
QNCX
$84.9M
$774 ﹤0.01%
469
-78
-14% -$129
DBEM icon
5530
Xtrackers MSCI Emerging Markets Hedged Equity ETF
DBEM
$73.6M
$773 ﹤0.01%
28
AKA icon
5531
a.k.a. Brands
AKA
$114M
$762 ﹤0.01%
74
-1,240
-94% -$12.8K
AXTI icon
5532
AXT Inc
AXTI
$156M
$754 ﹤0.01%
361
MARZ icon
5533
TrueShares Structured Outcome March ETF
MARZ
$15.8M
$753 ﹤0.01%
+23
New +$753
SGMT icon
5534
Sagimet Biosciences
SGMT
$229M
$747 ﹤0.01%
98
FTCI icon
5535
FTC Solar
FTCI
$102M
$734 ﹤0.01%
162
MCRB icon
5536
Seres Therapeutics
MCRB
$154M
$722 ﹤0.01%
65
VAL.WS icon
5537
Valaris Limited Warrants to purchase Common Shares
VAL.WS
$211M
0
-$952
SCD
5538
LMP Capital and Income Fund
SCD
$274M
$702 ﹤0.01%
45
-74
-62% -$1.15K
ADXN
5539
Addex Therapeutics
ADXN
$9.39M
$699 ﹤0.01%
+79
New +$699
EQX icon
5540
Equinox Gold
EQX
$8.58B
$696 ﹤0.01%
121
-172,450
-100% -$992K
PRPH icon
5541
ProPhase Labs
PRPH
$21.4M
$691 ﹤0.01%
1,765
-32
-2% -$13
STTK icon
5542
Shattuck Labs
STTK
$94.8M
$690 ﹤0.01%
871
-35,748
-98% -$28.3K
SPRO icon
5543
Spero Therapeutics
SPRO
$110M
$684 ﹤0.01%
236
-60,581
-100% -$176K
CLSD icon
5544
Clearside Biomedical
CLSD
$27.4M
$672 ﹤0.01%
840
-9,140
-92% -$7.31K
MMT
5545
MFS Multimarket Income Trust
MMT
$264M
$667 ﹤0.01%
+142
New +$667
RBOT icon
5546
Vicarious Surgical
RBOT
$34.6M
$661 ﹤0.01%
88
+7
+9% +$53
OFS icon
5547
OFS Capital
OFS
$117M
$658 ﹤0.01%
+78
New +$658
AVES icon
5548
Avantis Emerging Markets Value ETF
AVES
$804M
$643 ﹤0.01%
+12
New +$643
FTF
5549
Franklin Limited Duration Income Trust
FTF
$261M
$642 ﹤0.01%
+100
New +$642
CTMX icon
5550
CytomX Therapeutics
CTMX
$345M
$638 ﹤0.01%
281
-105,013
-100% -$238K